Agios Pharmaceuticals Inc. (AGIO)

51.98
0.29 0.55
NASDAQ : Health Technology
Prev Close 52.27
Open 52.56
Day Low/High 50.83 / 53.61
52 Wk Low/High 41.63 / 99.82
Volume 512.78K
Avg Volume 578.60K
Exchange NASDAQ
Shares Outstanding 58.18M
Market Cap 3.25B
EPS -6.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Agios Pharmaceuticals Inc.

(Graphic: Business Wire)

(Graphic: Business Wire)

Celgene Corporation (NASDAQ:CELG) and Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) today announced that IDHIFA ® (enasidenib) was granted approval from the U.

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP Announces Corporate Governance Investigation Of Agios Pharmaceuticals Inc. - AGIO

Newman Ferrara LLP announced today that the firm is conducting an investigation on behalf of shareholders of Agios Pharmaceuticals Inc.

TheStreet Quant Rating: D (Sell)